Hutner Capital Management Inc Abbott Laboratories Transaction History

Hutner Capital Management Inc

$207 Million
Q4 2024

A detailed history of Hutner Capital Management Inc transactions in Abbott Laboratories stock. As of the latest transaction made, Hutner Capital Management Inc holds 41,854 shares of ABT stock, worth $5.87 Million. This represents 2.29% of its overall portfolio holdings.

Number of Shares

41,854

Previous 41,950 0.23%

Holding current value

$5.87 Million

Previous $4.78 Million 1.0%

% of portfolio

2.29%

Previous 2.38%

29 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q4 2024 Feb 14, 2025	SELL	$111.93 - $119.39 $10,745 - $11,461	-96 Reduced 0.23%	41,854 $4.73 Million
Q3 2024 Nov 13, 2024	SELL	$100.07 - $118.13 $5,103 - $6,024	-51 Reduced 0.12%	41,950 $4.78 Million
Q2 2024 Aug 13, 2024	SELL	$100.73 - $112.44 $112,817 - $125,932	-1,120 Reduced 2.6%	42,001 $4.36 Million
Q1 2024 May 10, 2024	SELL	$109.52 - $120.96 $9,418 - $10,402	-86 Reduced 0.2%	43,121 $4.9 Million
Q4 2023 Feb 14, 2024	SELL	$90.19 - $110.4 $13,438 - $16,449	-149 Reduced 0.34%	43,207 $4.76 Million
Q3 2023 Nov 14, 2023	SELL	$95.53 - $114.62 $43,943 - $52,725	-460 Reduced 1.05%	43,356 $4.2 Million
Q2 2023 Aug 14, 2023	SELL	$100.78 - $112.29 $98,865 - $110,156	-981 Reduced 2.19%	43,816 $4.78 Million
Q1 2023 May 15, 2023	SELL	$96.86 - $114.01 $968 - $1,140	-10 Reduced 0.02%	44,797 $4.54 Million
Q4 2022 Feb 14, 2023	BUY	$95.06 - $111.52 $156,088 - $183,115	1,642 Added 3.8%	44,807 $4.92 Million
Q3 2022 Nov 14, 2022	BUY	$96.76 - $112.03 $119,111 - $137,908	1,231 Added 2.94%	43,165 $4.18 Million
Q2 2022 Aug 11, 2022	BUY	$102.07 - $123.37 $14,085 - $17,025	138 Added 0.33%	41,934 $4.56 Million
Q1 2022 May 13, 2022	SELL	$114.02 - $139.04 $15,962 - $19,465	-140 Reduced 0.33%	41,796 $4.95 Million
Q4 2021 Feb 11, 2022	SELL	$115.53 - $141.46 $1,964 - $2,404	-17 Reduced 0.04%	41,936 $5.9 Million
Q3 2021 Nov 12, 2021	SELL	$116.66 - $129.06 $22,282 - $24,650	-191 Reduced 0.45%	41,953 $4.96 Million
Q2 2021 Aug 13, 2021	SELL	$105.79 - $124.53 $311,445 - $366,616	-2,944 Reduced 6.53%	42,144 $4.89 Million
Q1 2021 May 18, 2021	BUY	$108.84 - $128.23 $79,779 - $93,992	733 Added 1.65%	45,088 $5.4 Million
Q4 2020 Feb 16, 2021	SELL	$105.0 - $114.42 $6,195 - $6,750	-59 Reduced 0.13%	44,355 $4.86 Million
Q3 2020 Nov 13, 2020	SELL	$91.64 - $111.29 $44,353 - $53,864	-484 Reduced 1.08%	44,414 $4.83 Million
Q2 2020 Aug 14, 2020	SELL	$76.57 - $98.0 $6,585 - $8,428	-86 Reduced 0.19%	44,898 $4.11 Million
Q1 2020 May 13, 2020	SELL	$62.82 - $91.86 $138,580 - $202,643	-2,206 Reduced 4.67%	44,984 $3.55 Million
Q3 2019 Nov 12, 2019	SELL	$81.84 - $88.74 $65,881 - $71,435	-805 Reduced 1.68%	47,190 $3.95 Million
Q2 2019 Aug 07, 2019	BUY	$72.88 - $85.0 $1,457 - $1,700	20 Added 0.04%	47,995 $4.04 Million
Q1 2019 May 10, 2019	SELL	$66.22 - $80.06 $96,019 - $116,087	-1,450 Reduced 2.93%	47,975 $3.84 Million
Q4 2018 Feb 12, 2019	BUY	$65.56 - $74.27 $7,539 - $8,541	115 Added 0.23%	49,425 $3.58 Million
Q3 2018 Nov 02, 2018	SELL	$60.81 - $73.36 $5,412 - $6,529	-89 Reduced 0.18%	49,310 $3.62 Million
Q2 2018 Jul 06, 2018	BUY	$57.57 - $63.54 $20,725 - $22,874	360 Added 0.73%	49,399 $3.01 Million
Q1 2018 Apr 06, 2018	SELL	$56.27 - $63.62 $8,721 - $9,861	-155 Reduced 0.32%	49,039 $2.94 Million
Q4 2017 Feb 01, 2018	BUY	$53.68 - $57.47 $90,504 - $96,894	1,686 Added 3.55%	49,194 $2.81 Million
Q3 2017 Oct 30, 2017	BUY	$48.06 - $53.64 $2.28 Million - $2.55 Million	47,508	47,508 $2.54 Million

Others Institutions Holding ABT

# of Institutions

3,371

Shares Held

1.36B

Call Options Held

10.6M

Put Options Held

8.73M

View Full List

About ABBOTT LABORATORIES

Ticker ABT
Exchange NYSE
Sector Healthcare
Industry Medical Devices
Shares Outstandng 1,751,219,968
Market Cap $246B
Description
Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...

More about ABT

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Hutner Capital Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Hutner Capital Management Inc with notifications on news.

Account

Hutner Capital Management Inc Abbott Laboratories Transaction History